Indaptus Therapeutics Inc. held a special meeting of shareholders on July 25, 2025. The meeting included two proposals related to a private placement. The first proposal, concerning the issuance of shares of common stock upon conversion of notes and exercise of warrants, was approved. The second proposal, regarding the issuance of shares to the Chief Executive Officer and Director upon conversion of notes and exercise of warrants, was also approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indaptus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-021377), on July 29, 2025, and is solely responsible for the information contained therein.